- Home
- EHAB vs HQL Comparison
EHAB vs HQL Comparison
Compare EHAB & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHAB
- HQL
- Stock Information
- Founded
- EHAB 2014
- HQL 1992
- Country
- EHAB United States
- HQL United States
- Employees
- EHAB N/A
- HQL N/A
- Industry
- EHAB Hospital/Nursing Management
- HQL Investment Managers
- Sector
- EHAB Health Care
- HQL Finance
- Exchange
- EHAB Nasdaq
- HQL Nasdaq
- Market Cap
- EHAB 401.6M
- HQL 369.6M
- IPO Year
- EHAB N/A
- HQL N/A
- Fundamental
- Price
- EHAB $7.66
- HQL $13.09
- Analyst Decision
- EHAB Buy
- HQL
- Analyst Count
- EHAB 2
- HQL 0
- Target Price
- EHAB $8.75
- HQL N/A
- AVG Volume (30 Days)
- EHAB 687.4K
- HQL 120.9K
- Earning Date
- EHAB 08-05-2025
- HQL 01-01-0001
- Dividend Yield
- EHAB N/A
- HQL 11.56%
- EPS Growth
- EHAB N/A
- HQL N/A
- EPS
- EHAB N/A
- HQL 0.79
- Revenue
- EHAB $1,032,300,000.00
- HQL N/A
- Revenue This Year
- EHAB $4.66
- HQL N/A
- Revenue Next Year
- EHAB $4.99
- HQL N/A
- P/E Ratio
- EHAB N/A
- HQL $17.08
- Revenue Growth
- EHAB N/A
- HQL N/A
- 52 Week Low
- EHAB $6.85
- HQL $11.34
- 52 Week High
- EHAB $10.91
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- EHAB 22.81
- HQL 63.34
- Support Level
- EHAB $9.06
- HQL $12.72
- Resistance Level
- EHAB $9.69
- HQL $12.87
- Average True Range (ATR)
- EHAB 0.34
- HQL 0.20
- MACD
- EHAB -0.26
- HQL 0.02
- Stochastic Oscillator
- EHAB 6.61
- HQL 97.40
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.